Turn Therapeutics Inc.
TTRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002023016
No open-market purchases or sales by Turn Therapeutics Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $8.48M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +9 vs. previous quarter
- 29
- 13F valueReported value at the end of Q2 2026
- $8.48M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding TTRX, Q2 2026
No superinvestor reported holding TTRX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Turn Therapeutics Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 (view filing) | Dec 12 | Same day | Chaudhary ZuraizSee Remarks | PPurchase | +2.50K | $3.50 | +$8.75K | +25.0%12.5K after | |
| Nov 25, 2025 (view filing) | Nov 24 | 1 day | Golden Arthur FDirector | PPurchase | +9.87K | $3.44 | +$33.9K | +19.5%60.6K after | |
| Nov 24, 2025 (view filing) | Nov 21 | 3 days | Golden Arthur FDirector | PPurchase | +20.5K | $2.87 | +$58.9K | +68.0%50.7K after | |
| Nov 21, 2025 (view filing) | Nov 20-21 | 1 day | Chaudhary ZuraizSee Remarks | PPurchase | +2.45K | $2.89 | +$7.07K | +32.5%10.0K after | 2 lots |
| Nov 17, 2025 (view filing) | Nov 17 | Same day | Chaudhary ZuraizSee Remarks | PPurchase | +2.50K | $3.62 | +$9.05K | +49.5%7.55K after | |
| Oct 29, 2025 (view filing) | Oct 23 | 6 daysLate | Chesed AbrahamOther: Board Observer | PPurchase | +14.3K | $4.60 | +$65.7K | +1.0%1.45M after | |
| Oct 23, 2025 (view filing) | Oct 23 | Same day | Chaudhary ZuraizSee Remarks | PPurchase | +5.05K | $4.95 | +$25.0K | New position5.05K after | |
| Oct 23, 2025 (view filing) | Oct 23 | Same day | Golden Arthur FDirector | PPurchase | +20.2K | $4.95 | +$100.0K | +202.0%30.2K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Turn Therapeutics Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Steel Peak Wealth Management LLC | 249,456 | $1.82M | 0.05% | +249,456 | New |
| Ieq Capital, LLC | 227,396 | $1.66M | 0.01% | +227,396 | New |
| DDFG, Inc | 107,829 | $787.2K | 0.16% | +37,295+52.9% | Added |
| Vanguard Capital Management LLC | 74,301 | $542.4K | 0.00% | +24,851+50.3% | Added |
| Wellington Shields & Co., LLC | 65,732 | $479.8K | 0.11% | 00.0% | Unchanged |
| Millennium Management LLC | 60,551 | $442.0K | 0.00% | −9,206−13.2% | Reduced |
| BlackRock, Inc. | 38,591 | $281.7K | 0.00% | +38,591 | New |
| Bridgewater Advisors Inc. | 27,326 | $241.6K | 0.01% | +27,326 | New |
| Aaron Wealth Advisors | 32,564 | $237.7K | 0.01% | +32,564 | New |
| Tamar Securities, LLC | 30,000 | $219.0K | 0.02% | 00.0% | Unchanged |